This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6b73
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='6b73' size='340' side='right'caption='[[6b73]], [[Resolution|resolution]] 3.10Å' scene=''> | <StructureSection load='6b73' size='340' side='right'caption='[[6b73]], [[Resolution|resolution]] 3.10Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[6b73]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[6b73]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli], [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Lama_glama Lama glama]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6B73 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6B73 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=CVV:N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide'>CVV</scene>, <scene name='pdbligand=OLA:OLEIC+ACID'>OLA</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.1Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=CVV:N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy-7,8-didehydro-4,5-epoxymorphinan-6-yl]-3-iodobenzamide'>CVV</scene>, <scene name='pdbligand=OLA:OLEIC+ACID'>OLA</scene></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6b73 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6b73 OCA], [https://pdbe.org/6b73 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6b73 RCSB], [https://www.ebi.ac.uk/pdbsum/6b73 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6b73 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [[ | + | [https://www.uniprot.org/uniprot/OPRK_HUMAN OPRK_HUMAN] G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain. Plays a role in mediating reduced physical activity upon treatment with synthetic opioids. Plays a role in the regulation of salivation in response to synthetic opioids. May play a role in arousal and regulation of autonomic and neuroendocrine functions.<ref>PMID:12004055</ref> <ref>PMID:22437504</ref> <ref>PMID:7624359</ref> <ref>PMID:8060324</ref> [https://www.uniprot.org/uniprot/C562_ECOLX C562_ECOLX] Electron-transport protein of unknown function. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 19: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 6b73" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 6b73" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Antibody 3D structures|Antibody 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Escherichia coli]] |
| - | [[Category: | + | [[Category: Homo sapiens]] |
| + | [[Category: Lama glama]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Carroll | + | [[Category: Carroll IF]] |
| - | [[Category: Che | + | [[Category: Che T]] |
| - | [[Category: Cherezov | + | [[Category: Cherezov V]] |
| - | [[Category: Han | + | [[Category: Han GW]] |
| - | [[Category: Huang | + | [[Category: Huang XP]] |
| - | [[Category: Katritch | + | [[Category: Katritch V]] |
| - | [[Category: Kormos | + | [[Category: Kormos C]] |
| - | [[Category: Krumm | + | [[Category: Krumm BE]] |
| - | [[Category: Lee | + | [[Category: Lee MY]] |
| - | [[Category: Majumdar | + | [[Category: Majumdar S]] |
| - | [[Category: McCorvy | + | [[Category: McCorvy JD]] |
| - | [[Category: Mosier | + | [[Category: Mosier PD]] |
| - | [[Category: Pardon | + | [[Category: Pardon E]] |
| - | [[Category: Pasternak | + | [[Category: Pasternak GW]] |
| - | [[Category: Roth | + | [[Category: Roth BL]] |
| - | [[Category: Stevens | + | [[Category: Stevens RC]] |
| - | [[Category: Steyaert | + | [[Category: Steyaert J]] |
| - | [[Category: Strachan | + | [[Category: Strachan RT]] |
| - | [[Category: Tribo | + | [[Category: Tribo AR]] |
| - | [[Category: Uprety | + | [[Category: Uprety R]] |
| - | [[Category: Vardy | + | [[Category: Vardy E]] |
| - | [[Category: Wacker | + | [[Category: Wacker D]] |
| - | [[Category: Wang | + | [[Category: Wang S]] |
| - | [[Category: Zaidi | + | [[Category: Zaidi SA]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Crystal Structure of a nanobody-stabilized active state of the kappa-opioid receptor
| |||||||||||
Categories: Escherichia coli | Homo sapiens | Lama glama | Large Structures | Carroll IF | Che T | Cherezov V | Han GW | Huang XP | Katritch V | Kormos C | Krumm BE | Lee MY | Majumdar S | McCorvy JD | Mosier PD | Pardon E | Pasternak GW | Roth BL | Stevens RC | Steyaert J | Strachan RT | Tribo AR | Uprety R | Vardy E | Wacker D | Wang S | Zaidi SA
